Gluon condensate in charmonium sum rules with three-loop corrections

Charmonium sum rules are analyzed with the primary goal to obtain the restrictions on the value of the dimension 4 gluon condensate. The moments M _n (Q ² ) of the polarization operator of the vector charm currents are calculated and compared with the experimental data. The three-loop () perturbative corrections, the contribution of the gluon condensate with corrections and the contribution of the dimension 6 operator G³ are accounted. It is shown that the sum rules for the moments do not work at Q ² = 0, where the perturbation series diverges and the G³ contribution is large. The domain in the (n, Q ² ) plane where the sum rules are legitimate is found. A strong correlation of the values of gluon condensate and charm quark mass is determined. The absolute limits are found to be for the gluon condensate and for the charm quark mass in the scheme. Received: 16 July 2002 / Revised version: 6 November 2002 / Published online: 24 January 2003 RID="a" ID="a" e-mail: ioffe@vitep1.itep.ru RID="b" ID="b" e-mail: zyablyuk@heron.itep.ru     

Formation of nitrogen heterocycles in reactions of O-nitrenes. Structures and properties of alkoxyaziridines (review)

The results of research on the synthesis of 1-alkoxyaziridines and 1-alkoxypyrrolines with the hypothetical participation of O-nitrenes generated by oxidation of o-alkylhydroxylamines are correlated.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 3, pp. 291–298, March, 1990.     

Unusual transformation of 2-nitropropane under the conditions of trimethylsilylation

Translated fromIzvestiya Akademii Nauk. Seriya Khimicheskaya, No. 6, pp. 1182–1183, June, 1995.     

Advances in the synthesis of 7-(3-cyclopentyloxy-4-methoxyphenyl)-hexahydro-3<Emphasis Type="Italic">H</Emphasis>-pyrrolizin-3-one (Pyrromilast)–a promising agent for treatment of chronic obstructive pulmonary disease

The review summarizes the known approaches to diastereo- and enantioselective synthesis of 7-(3-cyclopentyloxy-4-methoxyphenyl)hexahydro-3H-pyrrolizin-3-one (Pyrromilast), a highly active inhibitor of subtype 4B phosphodiesterase and a promising agent for treatment of chronic obstructive pulmonary disease.